IDA blend vs Japan: Cause of death, by non-communicable diseases, ages 5-14, female
IDA blend
26.3%
in 2021
Japan
62.9%
in 2021
IDA blend rank
29th
Japan rank
30th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- IDA blend
- Japan
How they compare
Japan currently reports 62.9% against 26.3% in IDA blend, a difference of 36.6%.
That makes Japan's figure about 2.4 times IDA blend's.
Across all 6 years both countries report, Japan has been ahead every year.
IDA blend ranks 29th and Japan ranks 30th of 47 groups.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.1% | 57.4% | 45.2% | Japan |
| 2010s | 19.3% | 63.7% | 44.3% | Japan |
| 2020s | 25.2% | 61.2% | 36.0% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, IDA blend or Japan?
- Japan, at 62.9% against 26.3% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between IDA blend and Japan?
- 36.6%, with Japan ahead.
- How many years of comparable data are there for IDA blend and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Japan rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- IDA blend ranks 29th and Japan ranks 30th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.